Paola Panina-Bordignon

Title: Paola Panina-Bordignon: Innovator in Immune Disease Treatment

Introduction

Paola Panina-Bordignon is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of immunology, particularly in the treatment of immune diseases. With a total of 3 patents, her work has garnered attention for its innovative approaches.

Latest Patents

Her latest patents include groundbreaking research on the treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists. These retinoids, which possess retinoid receptor antagonistic activity, have been found effective in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases. Another notable patent focuses on novel retinoid antagonists, which are crucial for advancing therapeutic options in this area.

Career Highlights

Paola is associated with Hoffmann-La Roche Inc., where she continues to push the boundaries of medical research. Her work has not only contributed to scientific knowledge but also holds the potential for real-world applications in treating allergic diseases.

Collaborations

Throughout her career, Paola has collaborated with esteemed colleagues, including Werner Bollag and Michael J Klaus. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Paola Panina-Bordignon stands out as an influential inventor in the realm of immune disease treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.